Mesterolone cas

In one small scale clinical trial of depressed patients, an improvement of symptoms which included anxiety, lack of drive and desire was observed. [16] In patients with dysthymia , unipolar , and bipolar depression significant improvement was observed. [16] In this series of studies, mesterolone lead to a significant decrease in luteinizing hormone and testosterone levels. [16] In another study, 100 mg mesterolone cipionate was administered twice monthly. [17] With regards to plasma testosterone levels, there was no difference between the treated versus untreated group, and baseline luteinizing hormone levels were minimally affected. [17]

Like other AAS, drostanolone is an agonist of the androgen receptor (AR). [3] It is not a substrate for 5α-reductase and is a poor substrate for 3α-hydroxysteroid dehydrogenase (3α-HSD), and therefore shows a high ratio of anabolic to androgenic activity. [3] As a DHT derivative, drostanolone is not a substrate for aromatase and hence cannot be aromatized into estrogenic metabolites . [3] While no data are available on the progestogenic activity of drostanolone, it is thought to have low or no such activity similarly to other DHT derivatives. [3] Since the drug is not 17α-alkylated , it is not known to cause hepatotoxicity . [3]

Mesterolone cas

mesterolone cas


mesterolone casmesterolone casmesterolone casmesterolone casmesterolone cas